Company: CDT
Filing Date: 2025-04-02
Form Type: 8-K/A
Source: 0001641172-25-002400
Chunk: 0

Company: CDT Equity Inc.
Filing Date: 2025-04-02
Form: 8-K/A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 31, 2025

Conduit Pharmaceuticals Inc.

(Exact name of registrant as specified in its charter)</div>

| Delaware              |     | 001-41245   |     | 87-3272543     |
| (State                
 or other jurisdiction |     | (Commission |     | (I.R.S.        
 Employer       |
| of                    
 incorporation)        |     | File        
 Number)     |     | Identification 
 No.)           |

| 4851                                       
 Tamiami Trail North, Suite 200, Naples, FL |     | 34103 |
| (Address                                   
 of principal executive offices)            |     |  -Zip 
  Code |

<div align='center'>(646) 491-9132

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)</div>

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

| ☐ | Written                                                                               
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         |
| ☐ | Soliciting                                                                            
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)           |
| ☐ | Pre-commencement                                                                      
 communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement                                                                      
 communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title                                                                  
 of Each Class                                                          |     | Trading   
 Symbol(s) |     | Name                                 
 of each exchange on which registered |
| Common                                                                 
 Stock, $0.0001 par value per share                                     |     | CDT       |     | The                                  
 Nasdaq Stock Market LLC              |
| Redeemable